Nuzenio

Tradingview Bdtx

Tradingview Bdtx entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 6 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Black Diamond Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:10:29 GMTBlack Diamond Therapeutics reports Q2 2026: $110.5M cash, $9.9M net loss - TradingViewTradingView · Wed, 05 Aug 2026 20:13:03 GMTBlack Diamond Therapeutics, Inc. 2Q 2026: Revenue $0 Net income ($9.91M), EPS ($0.17) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 20:11:00 GMTBlack Diamond Therapeutics Q2 net loss narrows year over year - TradingViewTradingView · Wed, 05 Aug 2026 20:08:35 GMTBDTX: Silevertinib demonstrated robust Phase 2 efficacy in NSCLC, supporting pivotal development plans - TradingViewTradingView · Wed, 05 Aug 2026 20:06:35 GMTBDTX: Net loss of $18.9M in H1 2026; cash reserves fund operations into late 2028, with further capital needed - TradingViewTradingView · Wed, 05 Aug 2026 20:06:00 GMTBDTX Q2'26 Earnings: EPS estimate is (0.20) USD - TradingViewTradingView · Wed, 05 Aug 2026 11:01:52 GMT

Timeline

Wed, 05 Aug 2026 21:10:29 GMTBlack Diamond Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView
Wed, 05 Aug 2026 20:13:03 GMTBlack Diamond Therapeutics reports Q2 2026: $110.5M cash, $9.9M net loss - TradingView
Wed, 05 Aug 2026 20:11:00 GMTBlack Diamond Therapeutics, Inc. 2Q 2026: Revenue $0 Net income ($9.91M), EPS ($0.17) — 10-Q Summary - TradingView
Wed, 05 Aug 2026 20:08:35 GMTBlack Diamond Therapeutics Q2 net loss narrows year over year - TradingView
Wed, 05 Aug 2026 20:06:35 GMTBDTX: Silevertinib demonstrated robust Phase 2 efficacy in NSCLC, supporting pivotal development plans - TradingView
Wed, 05 Aug 2026 20:06:00 GMTBDTX: Net loss of $18.9M in H1 2026; cash reserves fund operations into late 2028, with further capital needed - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Bdtx.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.